Between 2022 and 2032, the necrotizing fasciitis therapies market sales is projected to develop at a compound annual growth rate (CAGR) of 6.3% globally. The market is expected to grow at a rate of 4.2% yearly from its projection of US$ 2.4 billion for FY 2021 to US$ 2.5 billion. In addition, the industry is …